Nelson Laboratories, LLC

This whitepaper provides an overview of developing a comprehensive contamination control strategy (CCS), taking into consideration the various aspects of pharmaceutical manu

**Wednesday, November 17, 2021 at 11am EST, 10am CST, 8am PST*** TE&L examples are presented for which the critical toxicological endpoints are discussed and evaluated by means of various methods, in terms of deriving appropriate safety limits. *** On demand available after final airing until November 17, 2022.***

All drug products have to undergo sterility testing to comply with Good Manufacturing Practices (GMP). Parenteral drug products go through especially rigorous testing to ensure sterility and safety.